Back to Search Results

A review of newborn outcomes during the COVID-19 pandemic.

Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA; Division of Developmental Neuroscience, Psychiatry Department, Columbia University Irving Medical Center, New York, NY USA. Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA; NewYork-Presbyterian Hospital, New York, NY USA. Division of Neonatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA. NewYork-Presbyterian Hospital, New York, NY USA; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY USA. NewYork-Presbyterian Hospital, New York, NY USA; Division of Neonatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA. Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA. Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY USA. NewYork-Presbyterian Hospital, New York, NY USA; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA. NewYork-Presbyterian Hospital, New York, NY USA; Division of Pediatric Infectious Diseases, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA. Division of Developmental Neuroscience, Psychiatry Department, Columbia University Irving Medical Center, New York, NY USA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY USA; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA. Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA; NewYork-Presbyterian Hospital, New York, NY USA; Department of Population and Family Health, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY USA. Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY USA; Division of Developmental Neuroscience, Psychiatry Department, Columbia University Irving Medical Center, New York, NY USA; NewYork-Presbyterian Hospital, New York, NY USA; Sackler Institute, Zuckerman Institute, and the Columbia Population Research Center, Columbia University, New York, NY USA. Electronic address: dani.dumitriu@columbia.edu.

Seminars in perinatology. 2020;(7):151286
Full text from:

Other resources

Abstract

As the COVID-19 pandemic continues to spread worldwide, it is crucial that we determine populations that are at-risk and develop appropriate clinical care policies to protect them. While several respiratory illnesses are known to seriously impact pregnant women and newborns, preliminary data on the novel SARS-CoV-2 Coronavirus suggest that these groups are no more at-risk than the general population. Here, we review the available literature on newborns born to infected mothers and show that newborns of mothers with positive/suspected SARS-CoV-2 infection rarely acquire the disease or show adverse clinical outcomes. With this evidence in mind, it appears that strict postnatal care policies, including separating mothers and newborns, discouraging breastfeeding, and performing early bathing, may be more likely to adversely impact newborns than they are to reduce the low risk of maternal transmission of SARS-CoV-2 or the even lower risk of severe COVID-19 disease in otherwise healthy newborns.

Methodological quality

Publication Type : Review

Metadata